Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10
by from Morbidity and Mortality Weekly Report (MMWR) on (#61F2S)
This report describes the effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among adults